# Sanofi (Mexico) > organization **Wikidata**: [Q100956125](https://www.wikidata.org/wiki/Q100956125) **Source**: https://4ort.xyz/entity/sanofi-mexico ## Summary Sanofi (Mexico) is the Mexican subsidiary of the global pharmaceutical company Sanofi, headquartered in Mexico City. Established in 2004, it operates as a business entity engaged in commercial, industrial, and professional activities within the healthcare sector, focusing on the development, production, and distribution of pharmaceutical products in Mexico. ## Key Facts - **Name**: Sanofi (Mexico), also known as Sanofi-Aventis. - **Type**: Business (organization undertaking commercial, industrial, or professional activity). - **Parent Company**: Sanofi (global pharmaceutical corporation). - **Inception**: Founded in 2004. - **Headquarters**: Located in Mexico City, Mexico (coordinates: 19.347698, -99.180297). - **Country**: Mexico. - **Website**: [https://www.sanofi.com.mx/](https://www.sanofi.com.mx/). - **Identifiers**: - **ROR ID**: 05wd66v55. - **GRID ID**: grid.508751.e. - **Scilit Organization ID**: 98353. - **Classification**: Instance of a business, subclass of organization, economic entity, and juridical person. - **Primary Goal**: Generation of profit or economic profit. - **Ownership**: Owned by entrepreneurs (as part of the broader Sanofi corporation). - **Components**: Includes enterprise, economic activity, business sector, property, and human capital. - **Business Model**: Operates as a union of brick-and-mortar and virtual business models. - **Academic Focus**: Studied under business administration and business studies. ## FAQs **What is the relationship between Sanofi (Mexico) and the global Sanofi corporation?** Sanofi (Mexico) is a subsidiary of the global pharmaceutical company Sanofi, operating specifically within Mexico. It functions as an independent business entity while adhering to the broader corporate strategies and standards of its parent company. **Where is Sanofi (Mexico) headquartered?** Sanofi (Mexico) is headquartered in Mexico City, the capital and largest city of Mexico. The exact coordinates of its headquarters are 19.347698 latitude and -99.180297 longitude. **What type of business is Sanofi (Mexico) classified as?** Sanofi (Mexico) is classified as a business entity, which is a subclass of organization, economic entity, and juridical person. It is engaged in commercial, industrial, and professional activities, with a primary goal of generating profit. **What are the key identifiers associated with Sanofi (Mexico)?** Sanofi (Mexico) is identified by several unique codes, including: - **ROR ID**: 05wd66v55. - **GRID ID**: grid.508751.e. - **Scilit Organization ID**: 98353. These identifiers are used in academic, research, and business databases to uniquely reference the entity. **What is the significance of Sanofi (Mexico) in the Mexican pharmaceutical market?** Sanofi (Mexico) plays a crucial role in the Mexican healthcare sector by providing access to a wide range of pharmaceutical products. As part of a global corporation, it leverages international research, development, and distribution networks to address local health needs. ## Why It Matters Sanofi (Mexico) is a vital player in Mexico's healthcare ecosystem, contributing to the availability of essential medicines and treatments. As a subsidiary of a global pharmaceutical leader, it brings advanced medical innovations to the Mexican market, supporting public health initiatives and improving patient outcomes. Its presence in Mexico City, a major economic and cultural hub, further amplifies its impact by facilitating partnerships with local healthcare providers, research institutions, and government agencies. By operating within Mexico, Sanofi (Mexico) helps bridge the gap between global pharmaceutical advancements and local healthcare needs, ensuring that Mexican patients have access to high-quality medical solutions. ## Notable For - **Global Affiliation**: Being a subsidiary of Sanofi, one of the world's leading pharmaceutical companies. - **Strategic Location**: Headquartered in Mexico City, a key economic and political center in Latin America. - **Dual Business Model**: Operating as both a brick-and-mortar and virtual business, allowing for flexible and efficient operations. - **Academic and Research Contributions**: Engaging in business administration and studies, contributing to the broader understanding of pharmaceutical business operations. - **Unique Identifiers**: Possessing distinct identifiers (ROR ID, GRID ID, Scilit Organization ID) that facilitate its recognition in global databases. ## Body ### Overview and Classification Sanofi (Mexico) is a business entity that operates within the pharmaceutical sector in Mexico. It is classified as an instance of a business, which is a subclass of organization, economic entity, and juridical person. This classification aligns with its role as a commercial enterprise engaged in the development, production, and distribution of pharmaceutical products. The primary goal of Sanofi (Mexico) is to generate profit, which is a defining characteristic of its business model. ### Parent Company and Global Context Sanofi (Mexico) is part of the global Sanofi corporation, a multinational pharmaceutical company with a presence in numerous countries. As a subsidiary, Sanofi (Mexico) benefits from the research, development, and distribution networks of its parent company, allowing it to leverage global innovations and best practices in the Mexican market. This affiliation ensures that Sanofi (Mexico) can provide high-quality pharmaceutical products and solutions tailored to the needs of Mexican patients. ### Headquarters and Location The headquarters of Sanofi (Mexico) is located in Mexico City, the capital of Mexico. Mexico City is a major economic, cultural, and political hub in Latin America, making it an ideal location for Sanofi (Mexico) to establish its operations. The exact coordinates of the headquarters are 19.347698 latitude and -99.180297 longitude, placing it within the urban center of Mexico City. This strategic location facilitates easy access to key stakeholders, including healthcare providers, government agencies, and research institutions. ### Business Model and Operations Sanofi (Mexico) operates as a union of brick-and-mortar and virtual business models. This dual approach allows the company to maintain physical operations, such as manufacturing facilities and offices, while also leveraging digital platforms for distribution, marketing, and customer engagement. The brick-and-mortar aspect ensures a tangible presence in the Mexican market, while the virtual business model enhances efficiency and reach, particularly in remote or underserved areas. ### Key Identifiers and References Sanofi (Mexico) is recognized by several unique identifiers that facilitate its tracking and referencing in global databases: - **ROR ID**: 05wd66v55, which is used in research and academic contexts. - **GRID ID**: grid.508751.e, another identifier used in academic and research databases. - **Scilit Organization ID**: 98353, which helps in identifying the organization in scientific literature and publications. These identifiers are essential for ensuring that Sanofi (Mexico) is accurately represented in various knowledge bases and research platforms. ### Role in the Mexican Healthcare Sector Sanofi (Mexico) plays a significant role in the Mexican healthcare sector by providing access to a wide range of pharmaceutical products. The company's operations contribute to the availability of essential medicines, supporting public health initiatives and improving patient outcomes. By leveraging the resources and expertise of its global parent company, Sanofi (Mexico) is able to introduce advanced medical treatments and innovations to the Mexican market, addressing both common and complex health challenges. ### Academic and Research Contributions Sanofi (Mexico) is also involved in academic and research activities, particularly in the fields of business administration and business studies. The company's operations and strategies are studied to understand the dynamics of pharmaceutical business operations in emerging markets. This academic engagement helps in advancing the broader understanding of how multinational pharmaceutical companies can effectively operate and contribute to local healthcare systems. ### Relationship with Mexico City The location of Sanofi (Mexico) in Mexico City is strategically significant. Mexico City is not only the capital of Mexico but also a major economic and cultural center in Latin America. The city's infrastructure, including its transportation networks, healthcare facilities, and research institutions, provides a supportive environment for Sanofi (Mexico) to conduct its operations. Additionally, Mexico City's status as a global city enhances Sanofi (Mexico)'s ability to engage with international partners and stakeholders. ### Future Prospects As a subsidiary of a global pharmaceutical leader, Sanofi (Mexico) is well-positioned to continue its growth and impact in the Mexican healthcare sector. The company's ability to leverage global innovations, combined with its local expertise and strategic location, ensures that it will remain a key player in addressing the healthcare needs of the Mexican population. Future prospects include the introduction of new medical treatments, expanded research collaborations, and increased engagement with local healthcare providers and government agencies. ## References 1. GRID release 2020-10-06 2. ROR Data Dump 6.0 (October 2020)